1. US Department of Health and Human Services, Food and Drug Administration. Report: Complex issues in developing drugs and biological products for rare diseases and accelerating the development of therapies for pediatric rare diseases including strategic plan: accelerating the development of therapies for pediatric rare diseases. US FDA; 2014 [cited 2019 Jan 15]. Available from: https://www.fda.gov/media/89051/download.
2. Rare diseases, orphan drugs and their regulation: Questions and misconceptions;E Tambuyzer;Nat Rev Drug Discov,2010
3. Access to orphan drugs: A comprehensive review of legislations, regulations and policies in 35 countries;T Gammie;PLoS ONE,2015
4. Characteristics and Public Availability of Results of Clinical Trials on Rare Diseases Registered at Clinicaltrials.gov;A Dechartres;JAMA Intern Med,2016